Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 11
Submit an article Journal homepage
152
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

Kazuhito SuzukiDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan;Department of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan
,
Yasuhito TeruiDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Masahiro YokoyamaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Kyoko UedaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Noriko NishimuraDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Yuko MishimaDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Sakura SakajiriDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Naoko TsuyamaDepartment of Pathology
,
Kengo TakeuchiPathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
&
Kiyohiko HatakeDepartment of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, JapanCorrespondence[email protected]
 show all
Pages 2412-2417 | Received 03 Nov 2012, Accepted 21 Feb 2013, Published online: 14 Mar 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.